ArticleCancer medicine2022

Androgen-targeting therapeutics mitigate the adverse effect of GnRH agonist on the risk of neurodegenerative disease in men treated for prostate cancer.

Gregory L Branigan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.